Skip to content

Clinical trials

Immune System Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Country / region: Belgium Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20102
20122
20132
20171
20182
20193
20201
20211
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated6
Active, not recruiting2
Recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
AstraZeneca2
Cogent Biosciences, Inc.2
Pfizer2
UCB Pharma2
miRagen Therapeutics, Inc.2
Ariad Pharmaceuticals1
BioTech Tools S.A.1
Biogen1
Erasmus Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases19
Autoimmune Diseases8
Hypersensitivity6
Connective Tissue Diseases4
Neoplasms4
Hematologic Diseases3
Immunoproliferative Disorders3
Lupus Erythematosus, Systemic3
Lymphatic Diseases3
Lymphoproliferative Disorders3

Trials

Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.